IMA Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
IMA Advisory Services's VRTX Position: Q2 2026 in Review
IMA Advisory Services opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1 share worth $497. The stake represents ﹤0.01% of the portfolio and ranks #1269 among its holdings. This is a return to the name: IMA Advisory Services previously reported a position in VRTX as recently as Q2 2025.
IMA Advisory Services first reported a position in VRTX in Q2 2025 and has held it in 2 quarters since. The position peaked at $890 in Q2 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- IMA Advisory Services held 1 share of Vertex Pharmaceuticals worth $497 as of Q2 2026.
- Vertex Pharmaceuticals was a new IMA Advisory Services position in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1269 holding.
- IMA Advisory Services first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
- IMA Advisory Services's Vertex Pharmaceuticals position peaked at $890 in Q2 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.